SAR425899
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR425899, covering 2021-02-09 to 2021-02-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus [Phase 2]